| Tag | Content |
|---|
EnhancerAtlas ID | HS073-09489 |
Organism | Homo sapiens |
Tissue/cell | GM19238 |
Coordinate | chr21:34813110-34815200 |
Target genes | | Number: 12 | Name | Ensembl ID |
|
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Nr2f6(var.2) | MA0728.1 | chr21:34813320-34813335 | GAGGTCAGGAGTTCA | + | 6.22 | | Nr2f6(var.2) | MA0728.1 | chr21:34814156-34814171 | TGAACTCCTGACCTC | - | 6.22 | | PRDM1 | MA0508.2 | chr21:34814598-34814608 | GTGAAAGTGA | - | 6.02 | | Sox3 | MA0514.1 | chr21:34813726-34813736 | AAAACAAAGG | - | 6.02 |
|
| | Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
| SE_10924 | chr21:34810997-34818217 | CD20 | | SE_53174 | chr21:34814136-34815061 | Small_Intestine | | SE_53413 | chr21:34813900-34815231 | Spleen |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr21 | 34813586 | 34813888 | | chr21 | 34814324 | 34814936 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH21I033440 | chr21 | 34813197 | 34816050 |
|
Enhancer Sequence | CCTGGGAGGC AGAGGTTGCA GTGAGCCAAG ATTGCACCAC TGCACTCCAC CTGGGCGACA 60
GAGCAAGACT CTGTCTCAAA AAATAATAAT AAAATAAAAT AACGTCTCTG TCCATAGTGT 120
TTAAATCACA TAAAATGGAC TTCTGGCAGG GCACGGCGGC TCACACCTGT AATCCCAGCA 180
TTTTGGGAGG CTCAGGTGAG CGGATCGCCT GAGGTCAGGA GTTCAAGATC AGTCTGGCCA 240
ACAAGGTGAC ACCCTGTCTC TACTAAAAAT ACAAAAATCA GCCCAGCGCA GTGGCAGGTG 300
CCTGTAATCA CAGCTATTCA GGAGGCTGAG GCAGGAGAAT CGGTTGAACC CACAAGGTGG 360
AAGTTGCAGT GAGCCCAGAT GACACCACTG CACCTCAACC TGGGCAACAG AGCAAGAATC 420
TGTCTCAAAA AAAAAAAGGA CTTCTTGGTA CATAACATTT AAAGAAGCCT GCATAGTCAC 480
TATGGCCACT ATGTCTTTGA AGTGCCACAA CAGAGAGAGG CTCTCTGAAA GGAAATGATA 540
CTGATTTGGG AATAGGGTAT TACAAGGGGA ACACGTGTGC CAGAGTAAAC TATGTACATA 600
TTTAGGAAGG TGAAGGAAAA CAAAGGTTCT TAAAGGAAAA AATGAGGATT AGATCACTGT 660
TTTAAGATAA TTATCCTTGG CTATAAGGAT CAATAGCAAG GGGGATGCCA TTCCAAGGTT 720
AGACAGGCAG TTGTTGGGCA GATGTCCTCA TAGAAGTGTT TGTTGTGTAA GGCGGTGAAG 780
GGCTTTGTGC AAGGTTGAGA TTTTTGCAGT CTTTTGTGAT CATTTTTATT TATTTATTTA 840
TTTAGAGACA GAGTCTTGCT CTGTCACCCA AGCTGGAGGG CAGTGATGCA ATCACAGCTC 900
ACTGCAACGT CTGCCTCCTG GATTCAAGAA ATTCTCCTGT CTCAGCCTCC TTAGTAGCTG 960
GGACTACAGG CATCCGCCAC CATGCCTGGC TAATTTTTTG TATTTTTAGT AGAGATGGGA 1020
TTTTGCCATG TTGCCCAGGC TGGTCTTGAA CTCCTGACCT CAAGTGATCC ACCTGCCTCA 1080
ACCTTCTAAA ATGCTGGGAT TACAGGCATG AGCCACCACG CCCGGCCTTG TGATCATTTT 1140
TGTTATCAAG CATTTTTGCA TGAGAATCCT TCATGGCCTT CCCCAGCTCT ATTTGTCAGG 1200
GTTTTTTATT TGTTTGCTTG TTTGTTTGAA GCACAAGTGA CTCCATTTTG ATTCTGACAA 1260
CTTCCACACT ATGCAGTCAC ATCTCTGAGG CGCCCAGAGC CCTTCAAAAT ATATTTGCTG 1320
TTTGCCAAAT AGTCTCTATT TGAGATGAGA ACATCCCCAG CTGTCCTTCT GTTTGATGAG 1380
AAGTGAGACT CCACCCCAGC AGCTTCCGGA GATGCAGTCA TGCCTCCCCA CCCTTCACTG 1440
CCACTCCCAG CCTCCCTTGA GACTCAAGGA CTGTCCCACG GGAATGAAGT GAAAGTGACG 1500
TCTTTCTCCT TGTTTCCAGT CTGTGGTGAG GGAAAACAGC TGGCTACGCT TGAGAGGGTA 1560
TGGAAACTGG TCAGAGTGGT TACTTGGGAC CTGGGGCCTC AGAGCCACCC GTTGCTAAGG 1620
AGAGGACTCT GGTCAGGGCA ACTTGCCAAT GCTCTAGGAA TGACACCTAG ACATTCCTAA 1680
AAAATGATAG CCTAAAAATT CATCCCATTG TAGAAATACA GGCAGCACTA GCTTCTCTGG 1740
GCCCCTCAGT TATCAAAAAA AGAGGAGGGA GGCAGACCCT CAGGGTTACT TTACATCCAT 1800
ATACCTAGCT ACAACATAAA CATCAAATGA TATGTGGCCA GGCGCGCTGG CTCATGCCTG 1860
TAATCCCAGC ACTTTGGGAG GCAGAGGCAG GCAGATCACT TGAGGTCAGG AGTTCGACAC 1920
CAGCCTGGCC AACATGGAGA AACCCCGTCT CTACTAAAAA TACAAAAATT AGCCAGGCAT 1980
GATGGTGCAT GCCTGTAGTT CCAGCTACTC AGTAGGTTAA GGCATGAGAA TCGCTTGAAC 2040
CTGGGAGGCG GAGGTTGCAG TGAGCAAGAT CGTGCCACTG CACTCCAGCC 2090
|
